Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before Print

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research

Contents

Current Drug Targets, Volume 12 - Number 1








Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes

, 12(1): 88 - 96

Stefan Pilz, Andreas Tomaschitz, Christiane Drechsler, Armin Zittermann, Jacqueline M. Dekker and Winfried Marz


DOI: 10.2174/138945011793591563


Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?

, 12(1): 97 - 106

Martin H. de Borst, Rudolf A. de Boer, Ronald P. Stolk, Joris P.J. Slaets, Bruce H.R. Wolffenbuttel and Gerjan Navis


DOI: 10.2174/138945011793591590



Atherosclerosis, Degenerative Aortic Stenosis and Statins

, 12(1): 115 - 121

Giuseppina Novo, Giovanni Fazio, Claudia Visconti, Patrizia Carita, Ermanno Maira, Khalil Fattouch and Salvatore Novo


DOI: 10.2174/138945011793591545




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

Coronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog